Conversion from Platelet-Rich Plasma Platelet Production to Buffy Coat Platelet Component Production: Benefits and Limitations
Journal Title: Iranian Journal of Blood and Cancer - Year 2014, Vol 6, Issue 4
Abstract
Blood transfusion centers are under considerable pressure to produce platelet concentrates with high quality and safety due to the short shelf life of 3-5 days as well as possible bacterial and viral contaminations. For a variety of reasons, many Europeans have changed their methods of component production from whole blood using the North American standard platelet-rich plasma method to the buffy coat method of platelet production. Many advantages and some limitations during conversion from platelet-rich plasma method to buffy coat method have been observed. It seems that decisions to switch from platelet-rich plasma method to buffy coat method with whole blood component production should be considered the benefits from increased platelet yield, improved platelet quality, increased plasma recovery, reduced blood transfusion adverse reactions and lower pathogen transmission rates compared to the platelet-rich plasma method outweigh any transient difference in red cell parameters or inconsiderable reduction of factor VIII activity. The purpose of this review is to discuss the quality, safety and economic aspects of blood components production during conversion from platelet-rich plasma to buffy coat method in preparing blood components which may benefit developing countries.
Authors and Affiliations
S Nasiri
Keywords
Related Articles
- EP ID EP363437
- DOI -
- Views 91
- Downloads 0
Worldwide Supply and Demand of Plasma And Plasma-Derived Medicines
This article has no abstract.
Iron Stores in Male Blood Donors in Tehran Regional BloodTransfusion Center
Background: Iron deficiency and its related anemia, which is the world’s most widespread nutritional deficiency, can be one of the possible consequences of regular blood donation. This research was carried out to compare...
Hemoglobin E/β⁰ Thalassemia in south west Iran - A case series
Background: Beta thalassemia gene mutations are among common mutations in southwest Iran. However, Hemoglobin E (Hb E) and Hb E/β⁰ thalassemia account for a small number of hemoglobinopathies in Iran. This is the first s...
Cytotoxic Effects of Aqueous Extract of Portulaca oleracea on Oral Cancer Cell Line
Background: Portulaca oleracea as a herbal plant has been widely used in traditional medicine to cure many diseases. The therapeutic effects of this plant are exerted through its active ingredients with antioxidant prope...
Prevalence of Alloantibodies and Autoantibodies in Transfusion Dependent Thalassemia Patients
Background: The development of anti-red blood cell alloantibodies remains a major problem in transfusion of blood in thalassemia major patients. Also, Autoantibodies can result in clinical hemolysis and difficulty in cro...